Bank-In­de­pen­dent In­vest­ment Hou­se, GBC AG

GBC AG

Bank-In­de­pen­dent In­vest­ment Hou­se

GBC AG, headquartered in Augsburg, is one of the leading bank-independent investment houses in Germany and an experienced issuing expert for German SMEs.

As an owner-managed company, GBC AG knows the financing needs of German SMEs and is an independent and reliable partner for all capital market issues.

Within the GBC Group, GBC AG offers corporate analysis & research, capital market & financing consulting as well as capital market conferences.

GBC Kapital GmbH complements the services in the group with corporate finance in the areas of placement & brokerage of bonds and shares.

Equity Bottom-Up

<ul><li>MustGrow's equity story remains centred on the commercial scaling of TerraSante and the longer-term value potential of its Bayer partnership.</li><li>The first Bayer development milestone resulted in C$1.36m of high-margin licence revenue in H1 2026 and provides important external validation of the TerraMG technology.</li><li>Further upside could arise from potential additional milestone payments as the programme advances.</li></ul>

MustGrow's equity story remains centred on the commercial scaling of TerraSante and the longer-term value potential of its Bayer partnership.The first Bayer development milestone resulted in C$1.36m of high-margin licence revenue in H1 2026 and provides important external validation of the TerraMG technology.Further upside could arise from potential additional milestone payments as the programme advances.

Research Update english  – MustGrow Biologics Corp. –  28.09.2026

<ul><li>MustGrow Biologics Corp. is a Canadian agricultural biologicals company focused on mustard-derived technologies for soil health, crop nutrition, and crop protection.</li><li>The company operates in an attractive segment of the agricultural inputs market that benefits from rising demand for biological solutions, regenerative farming practices, and more sustainable alternatives to conventional chemistry.</li><li>MustGrow is no longer only an early-stage development platform.</li></ul>

MustGrow Biologics Corp. is a Canadian agricultural biologicals company focused on mustard-derived technologies for soil health, crop nutrition, and crop protection.The company operates in an attractive segment of the agricultural inputs market that benefits from rising demand for biological solutions, regenerative farming practices, and more sustainable alternatives to conventional chemistry.MustGrow is no longer only an early-stage development platform.

Research Report (Initial Coverage) english - MustGrow Biologics Corp. -  29.06.2026

<ul><li>Agriculture is undergoing a structural transformation.</li><li>Regulatory pressure, sustainability requirements, and the need to increase productivity on finite arable land are accelerating the shift toward biological and regenerative solutions.</li><li>Against this backdrop, MustGrow Biologics Corp. is positioning itself at the intersection of innovation, sustainability, and commercial agriculture.</li></ul>

Agriculture is undergoing a structural transformation.Regulatory pressure, sustainability requirements, and the need to increase productivity on finite arable land are accelerating the shift toward biological and regenerative solutions.Against this backdrop, MustGrow Biologics Corp. is positioning itself at the intersection of innovation, sustainability, and commercial agriculture.

Management-Interview english – MustGrow Biologics Corp. - 19.02.2026

Canada

MustGrow Biologics Corp. operates as an agriculture-biotech company. The Company focuses on the development and commercialization of non-synthetic AllylIsothiocyanate from mustard seed for use as a natural biofumigant for control of nematodes, soil-borne diseases, and other soil pests.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

MustGrow Biologics (MGRO CN)

Research Update english – MustGrow Biologics Corp. – 28.09.2026

MustGrow's equity story remains centred on the commercial scaling of TerraSante and the longer-term value potential of its Bayer partnership. The...

GBC AG

Research Report (Initial Coverage) english - MustGrow Biologics Corp. - 29.06.2026

MustGrow Biologics Corp. is a Canadian agricultural biologicals company focused on mustard-derived technologies for soil health, crop nutrition,...

GBC AG

Management-Interview english – MustGrow Biologics Corp. - 19.02.2026

Agriculture is undergoing a structural transformation. Regulatory pressure, sustainability requirements, and the need to increase productivity on...

GBC AG

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)